Loading...
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes
OBJECTIVES—To investigate a B-cell–depleting strategy to reverse diabetes in naïve NOD mice. RESEARCH DESIGN AND METHODS—We targeted the CD22 receptor on B-cells of naïve NOD mice to deplete and reprogram B-cells to effectively reverse autoimmune diabetes. RESULTS—Anti-CD22/cal monoclonal antibody (...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Diabetes Association
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2570398/ https://ncbi.nlm.nih.gov/pubmed/18689692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db08-0420 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|